Table Graph
      published meta-analysis   sensitivity analysis   studies

standard of care in COVID-19 mild to moderate - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsPLACID, 2020 (REV) 0.96 [0.61; 1.51] 0.96[0.61; 1.51]PLACID, 2020 (REV)10%464NAnot evaluable death or transfer to ICUdetailed resultsPLACID, 2020 (REV) 0.93 [0.64; 1.37] 0.93[0.64; 1.37]PLACID, 2020 (REV)10%464NAnot evaluable deathsdetailed resultsPLACID, 2020 (REV) 0.96 [0.61; 1.51] 0.96[0.61; 1.51]PLACID, 2020 (REV)10%464NAnot evaluable clinical deteriorationdetailed resultsPLACID, 2020 (REV) 0.96 [0.50; 1.84] 0.96[0.50; 1.84]PLACID, 2020 (REV)10%464NAnot evaluable mechanical ventilationdetailed resultsPLACID, 2020 (REV) 1.01 [0.55; 1.85] 1.01[0.55; 1.85]PLACID, 2020 (REV)10%451NAnot evaluable viral clearance by day 7detailed resultsPLACID, 2020 (REV) 0.83 [0.69; 1.00] 0.83[0.69; 1.00]PLACID, 2020 (REV)10%342NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-05-14 09:18 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 90 - treatments: 651 - roots T: 651

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons